Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology

KE Sapsford, WR Algar, L Berti, KB Gemmill… - Chemical …, 2013 - ACS Publications
Bionanotechnology has now become firmly established in its own right as one of the
principle and focused subdisciplines within nanotechnology.(1-10) Bionanotechnology can …

The multirole of liposomes in therapy and prevention of infectious diseases

R Nisini, N Poerio, S Mariotti, F De Santis… - Frontiers in …, 2018 - frontiersin.org
Liposomes are closed bilayer structures spontaneously formed by hydrated phospholipids
that are widely used as efficient delivery systems for drugs or antigens, due to their capability …

[HTML][HTML] Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide

A Vandergriff, KE Huang, D Shen, S Hu, MT Hensley… - Theranostics, 2018 - ncbi.nlm.nih.gov
Rationale: Cardiac stem cell-derived exosomes have been demonstrated to promote cardiac
regeneration following myocardial infarction in preclinical studies. Recent studies have used …

Liposomes: clinical applications and potential for image-guided drug delivery

N Lamichhane, TS Udayakumar, WD D'Souza… - Molecules, 2018 - mdpi.com
Liposomes have been extensively studied and are used in the treatment of several
diseases. Liposomes improve the therapeutic efficacy by enhancing drug absorption while …

Shaping Cancer Nanomedicine: The Effect of Particle Shape on The In Vivo Journey of Nanoparticles

R Toy, PM Peiris, KB Ghaghada, E Karathanasis - Nanomedicine, 2014 - Taylor & Francis
Recent advances in nanoparticle technology have enabled the fabrication of nanoparticle
classes with unique sizes, shapes and materials, which in turn has facilitated major …

Passive and active drug targeting: drug delivery to tumors as an example

VP Torchilin - Drug delivery, 2010 - Springer
The paradigm of using nanoparticulate pharmaceutical carriers has been well established
over the past decade, both in pharmaceutical research and in the clinical setting. Drug …

Liposomal paclitaxel formulations

Š Koudelka, J Turánek - Journal of Controlled Release, 2012 - Elsevier
Over the past three decades, taxanes represent one of the most important new classes of
drugs approved in oncology. Paclitaxel (PTX), the prototype of this class, is an anti-cancer …

Immunoliposomes: A review on functionalization strategies and targets for drug delivery

JO Eloy, R Petrilli, LNF Trevizan, M Chorilli - Colloids and Surfaces B …, 2017 - Elsevier
Nanoparticles, especially liposomes, have gained prominence in the field of drug delivery
for the treatment of human diseases, particularly cancer; they provide several advantages …

Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation

F Danhier, N Lecouturier, B Vroman, C Jérôme… - Journal of controlled …, 2009 - Elsevier
The purpose of this study was to develop Cremophor® EL-free nanoparticles loaded with
Paclitaxel (PTX), intended to be intravenously administered, able to improve the therapeutic …

Engineering nanosystems to overcome barriers to cancer diagnosis and treatment

SO Alhaj-Suliman, EI Wafa, AK Salem - Advanced drug delivery reviews, 2022 - Elsevier
Over the past two decades, multidisciplinary investigations into the development of
nanoparticles for medical applications have continually increased. However, nanoparticles …